Home › Pain After Surgery › NCT06812832
Simethicone as Part of ERAS in Bariatric Surgery Patients
Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol
Who can join
Ages 18 to 89 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Foregut procedures Exclusion Criteria: * Non-foregut procedures * Allergy to simethicone * Pregnancy or breastfeeding * Minors under 18 years of age
About the study
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery.
The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
What is being tested
- Simethicone 80 MG (drug)
- Placebo (drug)
Sponsor: Madigan Army Medical Center · Participants: 260 · Started: Apr 8, 2025
Contact the study team
- Brooklyn Williams, DO · Phone: (253) 968-3105
- Christopher Porta, MD · Phone: (253) 968-3105
Official record on ClinicalTrials.gov — NCT06812832
Locations in the U.S.
| Washington | Madigan Army Medical Center, Tacoma |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.